Up next

Autoplay

FDA Black Box Warning On Reglan Due To Side Effects Risk

1 Views • 08/24/25
Share
Side Effects
Side Effects
Subscribers
0

The FDA is requiring that manufacturers of Reglan (metoclopramide) add a boxed warning to the label about the risk of side effects from tardive dyskinesia if the drug is used for long periods of time or at high doses. Reglan stimulates motility in the upper GI tract and its uses include diabetic gastroparesis and gastroesophageal reflux disease. Reglan is marketed as a generic and under several trade names, including Reglan.

If you have been injured after using Reglan, contact the law office of Hissey Kientz by visiting us online at http://www.hkllp.com, or by emailing us at [email protected].

Show more
0 Comments sort Sort By

Up next

Autoplay